Polyphenols Modulate Alzheimer's Amyloid Beta Aggregation in a Structure-Dependent Manner

被引:64
|
作者
Phan, Huong T. T. [1 ]
Samarat, Kaouthar [1 ]
Takamura, Yuzuru [1 ]
Azo-Oussou, Auriane F. [2 ]
Nakazono, Yasutaka [2 ]
Vestergaard, Mun'delanji C. [2 ]
机构
[1] Japan Adv Inst Sci & Technol, 1-1 Asahidai, Nomi City, Ishikawa 9231292, Japan
[2] Kagoshima Univ, Dept Food Sci & Biotechnol, 1-21-24 Korimoto, Kagoshima 8908580, Japan
来源
NUTRIENTS | 2019年 / 11卷 / 04期
关键词
polyphenols; flavonoids; trans-stilbenes; bioactivity; amyloid beta aggregation; modulation; ELECTROCHEMICAL OXIDATION; ALPHA-SYNUCLEIN; FIBRILS; FLAVONOIDS; MECHANISM; PATHOLOGY; CURCUMIN; PEPTIDE; DAMAGE; IRON;
D O I
10.3390/nu11040756
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Some polyphenols, which are common natural compounds in fruits, vegetables, seeds, and oils, have been considered as potent inhibitors of amyloid beta (A) aggregation, one critical pathogenic event in Alzheimer's disease (AD). However, the mechanisms by which polyphenols affect aggregation are not fully understood. In this study, we aimed to investigate the effect of two classes of polyphenols (flavonoids and stilbenes) on the self-assembly of A_42, in particular, how this relates to structure. We found that the flavonoids gallocatechin gallate (GCG) and theaflavin (TF) could completely inhibit A aggregation, while two stilbenes, resveratrol and its glucoside derivative piceid, could also suppress A aggregation, but to a much lesser extent. Intriguingly, resveratrol accelerated the formation of A fibrils before its decreasing effect on fibrillation was detected. Atomic force microscopy (AFM) images showed a huge mass of long and thin A fibrils formed in the presence of resveratrol. Although the morphology was the same in the presence of piceid, the fibrils were sparse in the presence of picead. In the presence of flavonoids, A morphology was unchanged from prior to incubation (0 h), in agreement with amyloid beta kinetics analysis using thioflavin-T fluorescence assay. The electrochemical data showed a higher ability of GCG and TF to interact with A than resveratrol and piceid, which could be attributed to the presence of more aromatic rings and hydroxyl groups. In addition, the two flavonoids exhibited a similar propensity for A aggregation, despite having some differences in their structure. However, in the case of stilbenes, the addition of a glucoside at C-7 slightly decreased anti-A aggregation property compared to resveratrol. These findings contribute to a better understanding of the essential structural features of polyphenols required for inhibiting A aggregation, and the possible mechanisms for modulating aggregation.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Structure-dependent detection of polyphenols using crown ether-immobilized gold nanoparticles
    Yamaki, Yuto
    Seo, Hiroki
    Hatano, Akihiko
    Suzuki, Manabu
    Niikura, Kenichi
    RSC ADVANCES, 2024, 14 (24) : 16870 - 16875
  • [42] Allium roseumL. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer's disease
    Boubakri, Abdelbasset
    Leri, Manuela
    Bucciantini, Monica
    Najjaa, Hanen
    Ben Arfa, Abdelkarim
    Stefani, Massimo
    Neffati, Mohamed
    PLOS ONE, 2020, 15 (09):
  • [43] A rapid label-free electrochemical detection and kinetic study of Alzheimer's amyloid beta aggregation
    Vestergaard, M
    Kerman, K
    Saito, M
    Nagatani, N
    Takamura, Y
    Tamiya, E
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (34) : 11892 - 11893
  • [44] Spontaneous formation of β-sheet nano-barrels during the early aggregation of Alzheimer's amyloid beta
    Sun, Yunxiang
    Kakinen, Aleksandr
    Wan, Xulin
    Moriarty, Niamh
    Hunt, Cameron P. J.
    Li, Yuhuan
    Andrikopoulos, Nicholas
    Nandakumar, Aparna
    Davis, Thomas P.
    Parish, Clare L.
    Song, Yang
    Ke, Pu Chun
    Ding, Feng
    NANO TODAY, 2021, 38
  • [45] Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease
    Zhang, Wei
    Smith, Nathan
    Zhou, Yiqun
    McGee, Caitlin M.
    Bartoli, Mattia
    Fu, Shiwei
    Chen, Jiuyan
    Domena, Justin B.
    Joji, Annu
    Burr, Hannah
    Lv, Guohua
    Cilingir, Emel K.
    Bedendo, Susanna
    Claure, Matteo L.
    Tagliaferro, Alberto
    Eliezer, David
    Veliz, Eduardo A.
    Zhang, Fuwu
    Wang, Chunyu
    Leblanc, Roger M.
    ACTA BIOMATERIALIA, 2024, 183 : 341 - 355
  • [46] Oxidation of Methionine-35 in Alzheimer's amyloid-beta peptide and the aggregation of the oxidized peptide
    Friedemann, Merlin
    Helk, Eneken
    Tiiman, Ann
    Zovo, Kairit
    Palumaa, Peep
    Tougu, Vello
    SPRINGERPLUS, 2015, 4
  • [47] A rapid label-free electrochemical detection and kinetic study of Alzheimer's amyloid beta aggregation
    1600, American Chemical Society, Columbus, United States (127):
  • [48] Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease
    Clements, A
    Allsop, D
    Walsh, DM
    Williams, CH
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (02) : 740 - 747
  • [49] Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action
    Sharma, Sheetal
    Nehru, Bimla
    Saini, Avneet
    NEUROCHEMISTRY INTERNATIONAL, 2017, 108 : 481 - 493
  • [50] Metabolic genes modulate amyloid-beta toxicity in C-elegans Alzheimer's disease models
    Yan, X.
    Knight, A. L.
    Caldwell, K. A.
    Caldwell, G. A.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24